Streetbeat News

Products Services

KSCP

Knightscope, Inc. (NASDAQ:KSCP) has announced a new deployment of its K5 Autonomous Security Robots (ASRs) at a soccer academy and sports complex in Long Island, New York. The company has also renewed a contract with a Fortune 1000 hotel and resort chain client in the Seattle area for the second year. The hotel chain has over 6,500 properties globally, with more than 5,400 locations in the United States.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:35 pm

KKR

KKR & Co. Inc. is investing approximately $750 million in Zenobē, a provider of transport electrification and battery storage solutions, to accelerate the global decarbonization of diesel fleets. The investment is part of KKR's global climate strategy and will be used to meet the growing demand for EV adoption from bus operators and other commercial fleet businesses globally. KKR and current majority shareholder, Infracapital, will become joint majority shareholders of Zenobē.

Portfolio Pulse from Nabaparna Bhattacharya

September 07, 2023 | 1:34 pm

AREB

American Rebel's subsidiary Champion Safe has seen a surge in demand from safe dealers and customers seeking alternatives to safes made by Liberty Safe. This has led to a rise in American Rebel's share price.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:32 pm

DTSS

Datasea Inc. (NASDAQ:DTSS) has signed agreements with two new clients, Hainuo Xintong and Shenzhen Qiake Technology, to expand its 5G messaging service. The agreements allow the clients to purchase 5G message virtual recharge cards over the next 12 months. Since the agreements were signed, Datasea's Chinese operating entity and its subsidiaries have provided 5G messaging top-up services valued at approximately $1.89 million. In addition, ongoing services to pre-existing clients have generated approximately $1.06 million in revenue for August alone.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:31 pm

LUCD

PAVM

Lucid Diagnostics has released positive data from its first prospective clinical utility study of EsoGuard Esophageal DNA testing for the detection of esophageal precancer. This supplements its recently released positive data from a retrospective analysis of EsoGuard's clinical utility in firefighters.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:29 pm

ARQQ

ARQQW

Arqit Quantum is expanding its digital security offerings with a key agreement platform. The company is also in ongoing negotiations for the sale of its satellite division.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 1:28 pm

COYA

Coya Therapeutics (NASDAQ:COYA) has successfully engineered regulatory T cell derived exosomes with CTLA-4 protein to selectively target immune cells. This technology could potentially deliver targeted therapies across multiple diseases. The technology requires no genetic modifications and overcomes known limitations of exosome manipulation. The company's proprietary technology expands its pipeline to include autoimmune disorders and cancer.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:26 pm

ONDS

Airobotics, a company owned by Ondas Holdings (NASDAQ:ONDS), has become the first US company to receive the FAA's Airworthiness Certification for a Drone-In-A-Box. The Optimus-1EX Uncrewed Aircraft was granted a Type Certificate, allowing it to operate in complex urban environments. The certification was achieved after four years of intensive engineering and operational review processes. The Optimus System is already operating in the United Arab Emirates and Airobotics plans to conduct similar operations in urban environments across the U.S.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:23 pm

XELA

Exela Technologies (NASDAQ: XELA, XELAP) has signed a new customer for its Marketing Execution solution (XME). The customer, a large regional healthcare provider, was previously using multiple vendors leading to inefficiencies and escalating costs. Exela's XME solution will provide real-time reporting, inventory management, and print-on-demand, reducing costs and eliminating obsolete materials. The contract is estimated at $7.5 million and will be included in the ITPS segment which generated $765 million of revenue in 2022.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:22 pm

PHGE

BiomX Inc. (NYSE:PHGE) will present data from Part 1 of its ongoing Phase 1b/2a study evaluating the novel phage product candidate, BX004, for the treatment of chronic Pseudomonas aeruginosa pulmonary infections in patients with cystic fibrosis at the European Respiratory Society International Congress 2023. The data will also be available as an e-poster on the virtual congress platform.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 1:20 pm